Efficacy of plasma exchange in septic shock: A case report

Anaesthesiology Intensive Therapy

Volumn 46, Issue 2, 2014, Pages 92-95

  Sotłysiak, Jolanta ^a   Bartkowska Sńiatkowska, Alicja ^a   Rosada Kurasinśka, Jowita ^a   Lipkowska, Katarzyna ^a   Zachwieja, Jacek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Septic shock, children; Septic shock, treatment, therapeutic plasma exchange

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CATECHOLAMINE; DIURETIC AGENT; FIBRINOGEN; FRESH FROZEN PLASMA; MEROPENEM; NORADRENALIN; PROCALCITONIN; VANCOMYCIN; CALCITONIN; PROTEIN PRECURSOR;

ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHILD; CONTINUOUS INFUSION; END STAGE RENAL DISEASE; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; LEUKOCYTE COUNT; PERITONEAL DIALYSIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PNEUMONIA; PRESCHOOL CHILD; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; METABOLISM; PROCEDURES; SHOCK, SEPTIC; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; CALCITONIN; CATECHOLAMINES; CHILD, PRESCHOOL; FEMALE; HUMANS; PLASMA EXCHANGE; PROTEIN PRECURSORS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84901462505     PISSN: 16425758     EISSN: 17312531     Source Type: Journal    
DOI: 10.5603/AIT.2014.018     Document Type: Article

References (13)

1. Busund R, Koukline V, Utrobin U, Nedashkovsky E: Plasmaphersis in servere sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002; 28: 1434-1439.
2. Goldstein B, Giroir B, Randolph A et al.: International Pediatric Sepsis Consensus Conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2-8.
3. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed in time. Crit Care Med 1998; 26: 2078-2086. (Pubitemid 29016694)
4. House AA, Ronco C: Extracorporeal Blood Purification in Sepsis and Sepsis-Related Acute Kidney Injury. Blood Purif 2008; 26: 30-35.
5. Panacek EA, Marshall JC, Albertson TE et al.: Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004; 32: 2173-2182. (Pubitemid 39491795)
6. Szczepiorkowski ZM, Bandarenko N, Kim HC et al.: Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007; 22: 106-175. (Pubitemid 47025120)
7. Qu L, Kiss JE, Dargo G, Carcillo JA: Outcomes of previously helathy pediatric patients with fulminant sepsis-induced multisystem organ failure receiving therapeutic plasma exchange. J Clin Apher 2011; 26: 208-213.
8. Reeves JH: A review of plasma exchange in sepsis. Blood Purif 2002; 20: 282-288.
9. Kaplan AA: Renal disease. In: A practical guide to therapeutic plasma exchange. Blackwell Science Massachusetts 1999: 178-196.
10. Povoa P, Coelho LM, Salluh J: Usefulness of biomarkers in the clinical decision making process in sepsis. ICU Management 2010; 10: 22-28.
11. Maruna P, Nedelnikova K, Gurlich R: Physiology and genetics of procalcitonin. Physiol Res 2000; 49: 57-61.
12. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812. (Pubitemid 38057722)
13. Busund R, Lindsetmo RO, Rasmussen LT, Rokke O, Rekving OP, Revhaung A: Tumor necrosis factor and interleukin 1 appearance in experimental Gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion. Arch Surg 1991; 126: 591-597.